Brought to you by 
Actelion Ltd. closes $25.9mm private financing
13 Jul 1999
Executive Summary
Actelion, a Swiss company developing therapeutics for diseases involving the vascular endothelium, has raised $25.9mm in a private placement of 21,161 shares of Series B convertible preferred stock led by TVM Technoventure Management.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com